Goto

Collaborating Authors

From a $300 breast massager to a pregnancy band: The future of parenting revealed at CES

Daily Mail - Science & tech

Every year, the CES gadget show brings more devices promising to make life a little bit easier for harried parents. Sure, the kids might love them too: who wouldn't want a computerized Harry Potter wand that also teaches coding? The Las Vegas show's growing'family tech' sector encompasses products that range from artificially intelligent toys and baby monitors to internet-connected breast pumps. Among the standouts of this year's show was was a device designed to make breast pumping a smoother experience, complete with built-in breast massagers that can slash the total pumping time. Every year, the CES gadget show brings more devices promising to make life a little bit easier for harried parents.


Increasing Presence of AI at RSNA Reflects Emphasis on Efficiency

#artificialintelligence

Artificial intelligence (AI) sizzled at the Radiological Society of North America's (RSNA) 2018 meeting as vendors promoted new, old and unconventional technologies as means to increase efficiency throughout imaging. New releases were unveiled in imaging modalities, notably magnetic resonance imaging (MRI) and computed tomography (CT). But excitement was muted compared to enthusiasm for AI, which has been high for two years. Interest in AI was stoked by multiple medical societies at their annual meetings in the weeks leading up to RSNA 2018. The Radiological Society of North America contributed further through its decision to set up a machine learning showcase in the back of the North exhibit hall. Enthusiasm for enterprise imaging (EI) increased with the vendor promotion of AI software that promised to streamline workflow. This "coattail effect" was seen in multimodality exhibits including those of GE, Siemens, Philips and Canon, which promoted the use of AI not just to improve scanners, but to boost the performance of picture archive and communication systems (PACS) and vendor neutral archives (VNA) as well.


Lunit Showcases AI Solutions and Software at RSNA

#artificialintelligence

Lunit, a leading medical AI software company devoted to providing AI-powered total cancer care, will be returning to the 105th Radiological Society of North America (RSNA) this year with the latest, up-to-date AI solutions for chest and breast radiology. The state-of-the-art software--Lunit INSIGHT CXR 3 and Lunit INSIGHT MMG--will be available for demonstration at the Lunit booth located on AI Showcase floor, #10732. During RSNA 2019, Lunit will present key clinical study results conducted to validate the specific clinical utility of its products, along with other abstracts that study AI-driven mammography & DBT, and AI-based detection of chest abnormalities such as pneumothorax and tuberculosis. Lunit is one of the few companies in the industry that highlights evidence-based studies and publications. Lunit INSIGHT CXR and Lunit INSIGHT MMG, Lunit's most mature products tested on more than 3 million images from over 80 countries combined, will also be presented for demo.


SheThePeople on Twitter

#artificialintelligence

"Women just enter into a small booth, sit there for 15 minutes and come out, their test will be done. No one would have touched or seen them without clothes."


Accelerating Innovation and Adoption of Applications

#artificialintelligence

If you have something important to share but no way to distribute it to people, what good is it? Similarly, when a developer creates an innovative application, the platform is just as important as the application itself. With the new Edison Developer Program, GE Healthcare is selecting market-ready independent software vendors (ISVs) and developers to leverage the power of the Edison platform. This opportunity may help them to achieve faster adoption and experience commercial growth for their healthcare applications. It also fosters innovation within GE Healthcare's intelligence platform, where applications are built specifically for the needs of healthcare.